SANUWAVE Health Statistics
Total Valuation
SANUWAVE Health has a market cap or net worth of $287.82 million. The enterprise value is $306.70 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SANUWAVE Health has 8.58 million shares outstanding. The number of shares has increased by 174.14% in one year.
| Current Share Class | 8.58M |
| Shares Outstanding | 8.58M |
| Shares Change (YoY) | +174.14% |
| Shares Change (QoQ) | -0.30% |
| Owned by Insiders (%) | 5.83% |
| Owned by Institutions (%) | 19.78% |
| Float | 4.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 43.03 |
| PS Ratio | 6.89 |
| Forward PS | 5.69 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 224.84 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.43 |
| EV / EBITDA | 38.05 |
| EV / EBIT | 44.76 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.16
| Current Ratio | 1.16 |
| Quick Ratio | 0.73 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.03 |
| Debt / FCF | n/a |
| Interest Coverage | 0.85 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 14.91% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 42.77% |
| Revenue Per Employee | $897,457 |
| Profits Per Employee | -$153,130 |
| Employee Count | 46 |
| Asset Turnover | 1.44 |
| Inventory Turnover | 1.75 |
Taxes
In the past 12 months, SANUWAVE Health has paid $27,000 in taxes.
| Income Tax | 27,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.82% in the last 52 weeks. The beta is 1.33, so SANUWAVE Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.33 |
| 52-Week Price Change | +49.82% |
| 50-Day Moving Average | 33.38 |
| 200-Day Moving Average | 32.55 |
| Relative Strength Index (RSI) | 54.66 |
| Average Volume (20 Days) | 153,212 |
Short Selling Information
The latest short interest is 493,652, so 5.76% of the outstanding shares have been sold short.
| Short Interest | 493,652 |
| Short Previous Month | 523,540 |
| Short % of Shares Out | 5.76% |
| Short % of Float | 10.07% |
| Short Ratio (days to cover) | 3.38 |
Income Statement
In the last 12 months, SANUWAVE Health had revenue of $41.28 million and -$7.04 million in losses. Loss per share was -$1.08.
| Revenue | 41.28M |
| Gross Profit | 32.31M |
| Operating Income | 6.85M |
| Pretax Income | -7.02M |
| Net Income | -7.04M |
| EBITDA | 8.06M |
| EBIT | 6.85M |
| Loss Per Share | -$1.08 |
Full Income StatementBalance Sheet
The company has $9.60 million in cash and $24.45 million in debt, giving a net cash position of -$14.85 million or -$1.73 per share.
| Cash & Cash Equivalents | 9.60M |
| Total Debt | 24.45M |
| Net Cash | -14.85M |
| Net Cash Per Share | -$1.73 |
| Equity (Book Value) | -2.93M |
| Book Value Per Share | -0.34 |
| Working Capital | 3.06M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.30 million and capital expenditures -$2.08 million, giving a free cash flow of -$784,000.
| Operating Cash Flow | 1.30M |
| Capital Expenditures | -2.08M |
| Free Cash Flow | -784,000 |
| FCF Per Share | -$0.09 |
Full Cash Flow StatementMargins
Gross margin is 78.26%, with operating and profit margins of 16.60% and -17.06%.
| Gross Margin | 78.26% |
| Operating Margin | 16.60% |
| Pretax Margin | -17.00% |
| Profit Margin | -17.06% |
| EBITDA Margin | 19.53% |
| EBIT Margin | 16.60% |
| FCF Margin | n/a |
Dividends & Yields
SANUWAVE Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -174.14% |
| Shareholder Yield | -174.14% |
| Earnings Yield | -2.41% |
| FCF Yield | -0.27% |
Analyst Forecast
The average price target for SANUWAVE Health is $55.00, which is 63.89% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $55.00 |
| Price Target Difference | 63.89% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 18, 2024. It was a reverse split with a ratio of 1:375.
| Last Split Date | Oct 18, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:375 |
Scores
SANUWAVE Health has an Altman Z-Score of -4.02 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.02 |
| Piotroski F-Score | 6 |
